{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:18:07Z","timestamp":1793186287782,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,3]],"date-time":"2007-11-03T00:00:00Z","timestamp":1194048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2007,11,29]]},"DOI":"10.1007\/s00401-007-0306-6","type":"journal-article","created":{"date-parts":[[2007,11,2]],"date-time":"2007-11-02T11:02:50Z","timestamp":1194001370000},"page":"55-69","source":"Crossref","is-referenced-by-count":184,"title":["Huntington disease models and human neuropathology: similarities and differences"],"prefix":"10.1007","volume":"115","author":[{"given":"Jean Paul G.","family":"Vonsattel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,3]]},"reference":[{"key":"306_CR1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.410380602","volume":"38","author":"RL Albin","year":"1995","unstructured":"Albin RL (1995) Selective neurodegeneration in Huntington\u2019s disease. Ann Neurol 38:835\u2013836","journal-title":"Ann Neurol"},{"key":"306_CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/MB:32:2:147","volume":"32","author":"GP Bates","year":"2006","unstructured":"Bates GP, Gonitel R (2006) Mouse models of triplet repeat diseases. Mol Biotech 32:147\u2013158","journal-title":"Mol Biotech"},{"key":"306_CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357\u2013366","journal-title":"Ann Neurol"},{"key":"306_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","volume":"5","author":"MF Beal","year":"2004","unstructured":"Beal MF, Ferrante RJ (2004) Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease. Nat Rev Neurosci 5:373\u2013384. doi: 10.1038\/nrn1386","journal-title":"Nat Rev Neurosci"},{"key":"306_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","volume":"4","author":"MW Becher","year":"1998","unstructured":"Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA (1998) Intranuclear neuronal inclusions in Huntington\u2019s disease and dentatorubropallidoluysian atrophy: correlation between the density of inclusions and IT 15 CAG triplet repeat length. Neurobiol Dis 4:387\u2013397","journal-title":"Neurobiol Dis"},{"key":"306_CR6","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","volume":"63","author":"M Borrell-Pag\u00e8s","year":"2006","unstructured":"Borrell-Pag\u00e8s M, Zala D, Humbert S, Saudou F (2006) Huntington\u2019s disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63:2642\u20132660","journal-title":"Cell Mol Life Sci"},{"key":"306_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992) Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol 18:539\u2013547","journal-title":"Neuropathol Appl Neurobiol"},{"key":"306_CR8","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1523\/JNEUROSCI.0990-06.2006","volume":"2006","author":"HR Brignull","year":"2006","unstructured":"Brignull HR, Moore FE, Tang SJ, Morimoto RI (2006) Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci 2006:7597\u20137606. doi: 10.1523\/JNEUROSCI.0990-06.2006","journal-title":"J Neurosci"},{"key":"306_CR9","doi-asserted-by":"crossref","unstructured":"Brons IGM, Smithers LE, Trotter MWB, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, Vallier L (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. doi: 10.1038\/nature05950","DOI":"10.1038\/nature05950"},{"key":"306_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.23.6.561","volume":"23","author":"RK Byers","year":"1973","unstructured":"Byers RK, Gilles FH, Fung C (1973) Huntington\u2019s disease in children. Neurology 23:561\u2013569","journal-title":"Neurology"},{"key":"306_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/jnnp.24.1.71","volume":"24","author":"AMG Campbell","year":"1961","unstructured":"Campbell AMG, Corner B, Norman RM, Urich H (1961) The rigid form of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 24:71\u201377","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"306_CR12","unstructured":"Carpenter MB, Sutin J (eds) (1983) Human neuroanatomy, 8 edn. Williams & Wilkins, Baltimore\/London, pp 579\u2013586"},{"key":"306_CR13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6:919\u2013930. doi: 10.1038\/nrn1806","journal-title":"Nat Rev Neurosci"},{"key":"306_CR14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"J-H Cha","year":"2000","unstructured":"Cha J-H (2000) Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci 23:387\u2013392","journal-title":"Trends Neurosci"},{"key":"306_CR15","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","volume":"100","author":"MA Curtis","year":"2003","unstructured":"Curtis MA, Penney EB, Pearson AG, van Roon-Mom MC, Butterworth NJ, Dragunow M, Connor B, Faull RLM (2003) Increased cell proliferation and neurogenesis in the adult human Huntington\u2019s disease brain. Proc Natl Acad Sci USA 100:9023\u20139027. doi: 10.1073\/pnas.1532244100","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchemneu.2005.05.001","volume":"30","author":"MA Curtis","year":"2005","unstructured":"Curtis MA, Waldvogel HJ, Synek B, Faull RLM (2005) A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington\u2019s disease brain. J Chem Neutoanat 30:55\u201366. doi: 10.1016\/j.jchemneu.2005.05.001","journal-title":"J Chem Neutoanat"},{"key":"306_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"306_CR18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","volume":"47","author":"SM la Monte de","year":"1988","unstructured":"de la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease. J Neuropathol Exp Neurol 47:516\u2013525","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR19","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"306_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","volume":"46","author":"RJ Ferrante","year":"1987","unstructured":"Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington\u2019s disease. J Neuropathol Exp Neurol 46:12\u201327","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR21","unstructured":"Folstein SE (ed) (1989) The diagnosis of Huntington\u2019s disease. In: Huntington\u2019s disease. A disorder of families. The Johns Hopkins University Press, Baltimore, pp 125\u2013148"},{"key":"306_CR22","first-page":"453","volume":"1","author":"LS Forno","year":"1973","unstructured":"Forno LS, Jose C (1973) Huntington\u2019s chorea: a pathological study. Adv Neurol 1:453\u2013470","journal-title":"Adv Neurol"},{"key":"306_CR23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","volume":"20","author":"JMAC Gil","year":"2005","unstructured":"Gil JMAC, Mohapel P, Ara\u00fajo IM, Popovic N, Li J-Y, Brundin P, Peters\u00e9n A (2005) Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice. Neurobiol Dis 20:744\u2013751","journal-title":"Neurobiol Dis"},{"key":"306_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","volume":"49","author":"E G\u00f3mez-Tortosa","year":"2001","unstructured":"G\u00f3mez-Tortosa E, MacDonald ME, Friend JC, Taylor SAM, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel J-P, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol 49:29\u201334","journal-title":"Ann Neurol"},{"key":"306_CR25","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00001756-199806010-00028","volume":"9","author":"I Gourfinkel-An","year":"1998","unstructured":"Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw J-J, Trottier Y, Brice A, Agid Y, Hirsch EC (1998) Neuronal distribution of intranuclear inclusions in Huntington\u2019s disease with adult onset. Neuroreport 9:1823\u20131826","journal-title":"Neuroreport"},{"key":"306_CR26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.410420507","volume":"42","author":"I Gourfinkel-An","year":"1997","unstructured":"Gourfinkel-An I, Cancel G, Trottier Y, Devys D, Tora L, Lutz Y, Imbert G, Saudou F, Stevanin G, Agid Y, Brice A, Mandel J-L, Hirsch EC (1997) Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol 42:712\u2013719","journal-title":"Ann Neurol"},{"key":"306_CR27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, Warby SC, Doty CN, Roy S, Wellington CL, Leavitt BR, Raymond LA, Nicholson DW, Hayden MR (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191. doi: 10.1016\/j.cell.2006.04.026","journal-title":"Cell"},{"key":"306_CR28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"306_CR29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMcibr067022","volume":"356","author":"JT Greenamyre","year":"2007","unstructured":"Greenamyre JT (2007) Huntington\u2019s disease\u2014making connections. N Engl J Med Line 356:518\u2013520","journal-title":"NEJM"},{"key":"306_CR30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"Group: The Huntington\u2019s Disease Collaborative Research Group; MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, MacFarlane H, Jenkins B, Anderson MA, Wexler NS, Gusella JF (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"306_CR31","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1073\/pnas.92.19.8710","volume":"92","author":"C-A Gutekunst","year":"1995","unstructured":"Gutekunst C-A, Levey AI, Heilman GJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersch SM (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci USA 92:8710\u20138714","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR32","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"C-A Gutekunst","year":"1999","unstructured":"Gutekunst C-A, Li S-H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li X-J (1999) Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci 19:2522\u20132534","journal-title":"J Neurosci"},{"key":"306_CR33","first-page":"793","volume-title":"Handbuch der speziellen pathologischen Anatomie und Histologie (XIII\/1 Bandteil A)","author":"J Hallervorden","year":"1957","unstructured":"Hallervorden J (1957) Huntingtonsche Chorea (Chorea chronica progressiva hereditaria). In: Handbuch der speziellen pathologischen Anatomie und Histologie (XIII\/1 Bandteil A). Springer, Berlin, pp 793\u2013822"},{"key":"306_CR34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/exnr.1998.6919","volume":"154","author":"GM Halliday","year":"1998","unstructured":"Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E (1998) Regional specificity of brain atrophy in Huntington\u2019s disease. Exp Neurol 154:663\u2013672","journal-title":"Exp Neurol"},{"key":"306_CR35","first-page":"37","volume-title":"Huntington\u2019s disease. Major problems in neurology, vol 22","author":"PS Harper","year":"1991","unstructured":"Harper PS, Morris MR, Quarrell OWJ, Shaw DJ, Tyler A, Youngman S (1991) The clinical neurology of Huntington\u2019s disease. In: Huntington\u2019s disease. Major problems in neurology, vol 22. W.B. Saunders, London, pp 37\u201380"},{"key":"306_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","volume":"133","author":"JC Hedreen","year":"1991","unstructured":"Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease. Neurosci Lett 133:257\u2013261","journal-title":"Neurosci Lett"},{"key":"306_CR37","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","volume":"9","author":"P Hilditch-Maguire","year":"2000","unstructured":"Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald M (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9:2789\u20132797","journal-title":"Hum Mol Genet"},{"key":"306_CR38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","volume":"51","author":"E Hockly","year":"2002","unstructured":"Hockly E, Cordery PM, Woodman B, Mahal A, van Dellen A, Blakemore C, Lewis CM, Hannan AJ, Bates GP (2002) Environmental enrichment slows disease progression in R6\/2 Huntington\u2019s disease mice. Ann Neurol 51:235\u2013242. doi: 10.1002\/ana.10094","journal-title":"Ann Neurol"},{"key":"306_CR39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst C-A, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li X-J, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:182\u2013192","journal-title":"Neuron"},{"key":"306_CR40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel J-P, MacDonald ME, Gusella JF (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24:217\u2013233","journal-title":"Somat Cell Mol Genet"},{"key":"306_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jnr.1153","volume":"65","author":"H Ishiguro","year":"2001","unstructured":"Ishiguro H, Yamada K, Sawada H, Nishii K, Ichino N, Sawada M, Kurosawa Y, Matsushita N, Kobayashi K, Goto J, Hashida H, Masuda N, Kanazawa I, Nagatsu T (2001) Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington\u2019s disease gene. J Neurosci Res 65:289\u2013297","journal-title":"J Neurosci Res"},{"key":"306_CR42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archneur.1963.00460090050005","volume":"9","author":"GA Jervis","year":"1963","unstructured":"Jervis GA (1963) Huntington\u2019s chorea in childhood. Arch Neurol 9:244\u2013257","journal-title":"Arch Neurol"},{"key":"306_CR43","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin Z-H, Chen JD, Nevins JR, Aronin N, DiFiglia M (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476","journal-title":"J Biol Chem"},{"key":"306_CR44","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/hmg\/9.17.2539","volume":"9","author":"L Kennedy","year":"2000","unstructured":"Kennedy L, Shelbourne PF (2000) Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington\u2019s disease? Hum Mol Genet 9:2539\u20132544","journal-title":"Hum Mol Genet"},{"key":"306_CR45","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin B, Bassett A, Almqvist E, Bird TD, Hayden MR (1994) A worldwide study of the Huntington\u2019s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med Line 330:1401\u20131406","journal-title":"N Engl J Med Line"},{"key":"306_CR46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","volume":"46","author":"S Kuemmerle","year":"1999","unstructured":"Kuemmerle S, Gutekunst C-A, Klein AM, Li X-J, Li S-H, Beal MF, Hersch SM, Ferrante RJ (1999) Huntingtin aggregates may not predict neuronal death in Huntington\u2019s disease. Ann Neurol 46:842\u2013849","journal-title":"Ann Neurol"},{"key":"306_CR47","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha J-HJ, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, Albin R, Shelbourne P, Delorenzi M, Augood SJ, Faull RLM, Olson JM, Bates GP, Jones L, Luthi-Carter R (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861. doi: 10.1093\/hmg\/ddm133","journal-title":"Hum Mol Genet"},{"key":"306_CR48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410370213","volume":"37","author":"GB Landwehrmeyer","year":"1995","unstructured":"Landwehrmeyer GB, McNeil SM, Dure LS IV, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E, de Young M, Avila-Gonzales AJ, Wexler NS, DiFiglia M, Gusella JF, MacDonald ME, Penney JB, Young AB, Vonsattel JP (1995) Huntington\u2019s disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218\u2013230","journal-title":"Ann Neurol"},{"key":"306_CR49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0022-510X(76)90114-3","volume":"28","author":"H Lange","year":"1976","unstructured":"Lange H, Th\u00f6rner G, Hopf A, Schr\u00f6der KF (1976) Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28:401\u2013425","journal-title":"J Neurol Sci"},{"key":"306_CR50","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","volume":"15","author":"SE Lazic","year":"2004","unstructured":"Lazic SE, Grote H, Armstrong JE, Blakemore C, Hannan AJ, van Dellen A, Barker RA (2004) Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice. Neuroreport 15:811\u2013813. doi: 10.1097\/01.wnr.0000122486.43641.90","journal-title":"Neuroreport"},{"key":"306_CR51","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","volume":"23","author":"SE Lazic","year":"2006","unstructured":"Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, PhillipsW, Barker RA (2006) Neurogenesis in the R6\/1 transgenic mouse model of Huntington\u2019s disease: effects of environmental enrichment. Eur J Neurosci 23:1829\u20131838. doi: 10.1111\/j.1460-9568.2006.04715.x","journal-title":"Eur J Neurosci"},{"key":"306_CR52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","volume":"27","author":"MS Levine","year":"2004","unstructured":"Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet M-F (2004) Genetic mouse models of Huntington\u2019s and Parkinson\u2019s disease: illuminating but imperfect. Trends Neurosci 27:691\u2013697","journal-title":"Trends Neurosci"},{"key":"306_CR53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","volume":"58","author":"MS Levine","year":"1999","unstructured":"Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet M-F (1999) Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington\u2019s disease. J Neurosci Res 58:515\u2013532","journal-title":"J Neurosci Res"},{"key":"306_CR54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/78054","volume":"25","author":"H Li","year":"2000","unstructured":"Li H, Li S-H, Johnston H, Shelbourne PF, Li S-J (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25:385\u2013389","journal-title":"Nat Genet"},{"key":"306_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"C-H Lin","year":"2001","unstructured":"Lin C-H, Tallaksen-Greene S, Chien W-M, Cearley JA, Jackson WS, Crouse AB, Ren S, Li X-J, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"306_CR56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. doi: 10.1038\/nature05292","journal-title":"Nature"},{"key":"306_CR57","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM (2002) Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911\u20131926","journal-title":"Hum Mol Genet"},{"key":"306_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005072-199902000-00003","volume":"58","author":"MLC Maat-Schieman","year":"1999","unstructured":"Maat-Schieman MLC, Dorsman JC, Smoor MA, Siesling S, van Duinen SG, Verschuuren JGM, den Dunnen JT, van Ommen G-JB, Roos AC (1999) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 58:129\u2013137","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2990.1997.tb01326.x","volume":"23","author":"V Macdonald","year":"1997","unstructured":"Macdonald V, Halliday GM, Trent RJ, McCusker EA (1997) Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington\u2019s disease. Neuropathol Appl Neurobiol 23:492\u2013495","journal-title":"Neuropathol Appl Neurobiol"},{"key":"306_CR60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"306_CR61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1471-4914(01)02179-7","volume":"7","author":"RL Margolis","year":"2001","unstructured":"Margolis RL, Roos CA (2001) Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol Med 7:479\u2013482. doi: 10.1016\/S1471-4914(01)02179-7","journal-title":"Trends Mol Med"},{"key":"306_CR62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(65)80303-1","volume":"67","author":"CH Markham","year":"1965","unstructured":"Markham CH, Knox JW (1965) Observations on Huntington\u2019s chorea in childhood. J Pediatr 67:46\u201357","journal-title":"J Pediatr"},{"key":"306_CR63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00005053-196108000-00001","volume":"133","author":"WTE McCaughey","year":"1961","unstructured":"McCaughey WTE (1961) The pathologic spectrum of Huntington\u2019s chorea. J Nerv Ment Dis 133:91\u2013103","journal-title":"J Nerv Ment Dis"},{"key":"306_CR64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","volume":"23","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Chesselet M-F (2002) Mouse models of Huntington\u2019s disease. Trends Pharmacol Sci 23:32\u201339","journal-title":"Trends Pharmacol Sci"},{"key":"306_CR65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet M-F (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 465:11\u201326","journal-title":"J Comp Neurol"},{"key":"306_CR66","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","volume":"22","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Sison JD, Wu U, Olivieri M, Li X-J, Li H, Zeitlin S, Chesselet M-F (2002) Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington\u2019s disease knock-in mice. J Neurosci 22:8266\u20138276","journal-title":"J Neurosci"},{"key":"306_CR67","first-page":"615","volume":"45","author":"RH Myers","year":"1989","unstructured":"Myers RH, Leavitt J, Farrer LA, Jagadeesh J, McFarlane H, Mastromauro CA, Mark RJ, Gusella JF (1989) Homozygote for Huntington disease. Am J Hum Genet 45:615\u2013618","journal-title":"Am J Hum Genet"},{"key":"306_CR68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 50:729\u2013742","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","volume":"38","author":"RH Myers","year":"1988","unstructured":"Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, Martin JB, Bird ED (1988) Clinical and neuropathologic assessment of severity in Huntington\u2019s disease. Neurology 38:341\u2013347","journal-title":"Neurology"},{"key":"306_CR70","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/WNL.52.2.392","volume":"52","author":"MA Nance","year":"1999","unstructured":"Nance MA, Mathias-Hagen V, Breningstall G, Wick MJ, McGlennen RC (1999) Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington\u2019s disease. Neurology 52:392\u2013394","journal-title":"Neurology"},{"key":"306_CR71","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora","year":"2001","unstructured":"Nucifora FC, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA (2001) Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291:2423\u20132428","journal-title":"Science"},{"key":"306_CR72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","volume":"24","author":"K Obrietan","year":"2004","unstructured":"Obrietan K, Hoyt KR (2004) CRE-mediated transcription is increased in Huntington\u2019s disease transgenic mice. J Neurosci 24:791\u2013796. doi: 10.1523\/JNEUROSCI.3493-03-2004","journal-title":"J Neurosci"},{"key":"306_CR73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621. doi: 10.1146\/annurev.neuro.29.051605.113042","journal-title":"Annu Rev Neurosci"},{"key":"306_CR74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/302269","volume":"64","author":"HL Paulson","year":"1999","unstructured":"Paulson HL (1999) Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. Hum Genet 64:339\u2013345","journal-title":"Hum Genet"},{"key":"306_CR75","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","volume":"25","author":"W Phillips","year":"2005","unstructured":"Phillips W, Morton AJ, Barker RA (2005) Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in vivo microenvironment. J Neurosci 25:11564\u201311576. doi: 10.1523\/JNEUROSCI.3796-05.2005","journal-title":"J Neurosci"},{"key":"306_CR76","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Project: The US\u2014Venezuela Collaborative Research Project, Wexler NS (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA 101:3498\u20133503","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"PH Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO Jr, Miller G, Tagle DA (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20:198\u2013202","journal-title":"Nat Genet"},{"key":"306_CR78","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733\u20135737","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR79","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2990.1990.tb01285.x","volume":"16","author":"EP Richardson Jr","year":"1990","unstructured":"Richardson EP Jr (1990) Huntington\u2019s disease: some recent neuropathological studies. Neuropathol Appl Neurobiol 16:451\u2013460","journal-title":"Neuropathol Appl Neurobiol"},{"key":"306_CR80","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.410370309","volume":"37","author":"EK Richfield","year":"1995","unstructured":"Richfield EK, Maguire-Zeiss KA, Cox C, Gilmore J, Voorn P (1995) Reduced expression of preproenkephalin in striatal neurons from Huntington\u2019s disease patients. Ann Neurol 37:335\u2013343","journal-title":"Ann Neurol"},{"key":"306_CR81","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu G-Q, Mucke L (2007) Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316:750\u2013754. doi: 10.1126\/science.1141736","journal-title":"Science"},{"key":"306_CR82","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1750-3639.1997.tb00893.x","volume":"7","author":"Y Robitaille","year":"1997","unstructured":"Robitaille Y, Lopes-Cendes I, Becher M, Rouleau G, Clark AW (1997) The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol 7:901\u2013926","journal-title":"Brain Pathol"},{"key":"306_CR83","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp.48.5.422","volume":"48","author":"RAC Roos","year":"1985","unstructured":"Roos RAC, Pruyt JFM, de Vries J, Bots GTAM (1985) Neuronal distribution in the putamen in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 48:422\u2013425","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"306_CR84","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM199610173351609","volume":"335","author":"RN Rosenberg","year":"1996","unstructured":"Rosenberg RN (1996) DNA-triplet repeats and neurologic disease. N Engl J Med Line 335:1222\u20131224","journal-title":"N Engl J Med Line"},{"key":"306_CR85","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein DC (2002) Lessons from animal models of Huntington\u2019s disease. Trends Genet 18:202\u2013209","journal-title":"Trends Genet"},{"key":"306_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","volume":"5","author":"DC Rubinsztein","year":"2003","unstructured":"Rubinsztein DC, Carmichael J (2003) Huntington\u2019s disease: molecular basis of neurodegeneration. Expert Rev Mol Med 5:1\u201321. doi: 10.1017\/S1462399403006549","journal-title":"Expert Rev Mol Med"},{"key":"306_CR87","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman J-J, Chotai K, Connarty M, Craufurd D, Curtis A, Curtis D, Davidson MJ, Differ A-M, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Jackson A, Kaplan J-C, Losekoot M, MacMillan JC, Morrison P, Trottier Y, Novelletto A, Simpson S, Theilmann J, Whittaker JL, Folstein SE, Ross CA, Hayden MR (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59:16\u201322","journal-title":"Am J Hum Genet"},{"key":"306_CR88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","volume":"64","author":"E Sapp","year":"1995","unstructured":"Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel J-P, DiFiglia M (1995) Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis. Neuroscience 64:397\u2013404","journal-title":"Neuroscience"},{"key":"306_CR89","first-page":"829","volume":"25","author":"E Sapp","year":"1999","unstructured":"Sapp E, Kegel KB, Aronin N, Yohyama K, Uchiyama Y, Bhide P, Vonsattel JP, DiFiglia M (1999) Microglia accumulate in the HD striatum and cortex. Soc Neurosci 25:829","journal-title":"Soc Neurosci"},{"key":"306_CR90","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199902000-00006","volume":"58","author":"E Sapp","year":"1999","unstructured":"Sapp E, Penney J, Young AB, Aronin N, Vonsattel J-P, DiFiglia M (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58:165\u2013173","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR91","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","volume":"42","author":"E Sapp","year":"1997","unstructured":"Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington\u2019s disease patients. Ann Neurol 42:604\u2013612","journal-title":"Ann Neurol"},{"key":"306_CR92","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","volume":"8","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F, Wanker EE, Doherty P, Davies SW, Bates GP (1999) Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 8:813\u2013822","journal-title":"Hum Mol Genet"},{"key":"306_CR93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549\u2013558","journal-title":"Cell"},{"key":"306_CR94","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"306_CR95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","volume":"8","author":"PF Shelbourne","year":"1999","unstructured":"Shelbourne PF, Killeen N, Hevner RF, Johnston HM, Tecott L, Lewandoski M, Ennis M, Ramirez L, Li Z, Iannicola C, Littman DR, Myers RM (1999) A Huntington\u2019s disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet 8:763\u2013774","journal-title":"Hum Mol Genet"},{"key":"306_CR96","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","volume":"102","author":"EJ Slow","year":"2005","unstructured":"Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, Deng Y, Pearson J, Vaid K, Bissada N, Wetzel R, Leavitt BR, Hayden MR (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci USA 102:11402\u201311407","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR97","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang Y-Z, Li X-J, Simpson EM, Gutekunst C-A, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"306_CR98","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/WNL.41.7.1117","volume":"41","author":"A Sotrel","year":"1991","unstructured":"Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH (1991) Morphometric analysis of the prefrontal cortex in Huntington\u2019s disease. Neurology 41:1117\u20131123","journal-title":"Neurology"},{"key":"306_CR99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D, Bachoud-L\u00e9vi A-C, Simpson SA, Delatycki M, Maglione V, Hayden MR, Di Donato S (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126:946\u2013955","journal-title":"Brain"},{"key":"306_CR100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238. doi: 10.1016\/S0168-9525(03)00074-X","journal-title":"Trends Genet"},{"key":"306_CR101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, Adam S, Greenberg C, Ives EJ, Clarke LA, Hayden MR (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet 6:409\u2013414","journal-title":"Nat Genet"},{"key":"306_CR102","doi-asserted-by":"crossref","unstructured":"Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RDG (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature. doi: 10.1038\/nature05972","DOI":"10.1038\/nature05972"},{"key":"306_CR103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel J-L (1995) Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature 378:403\u2013406","journal-title":"Nature"},{"key":"306_CR104","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","volume":"97","author":"M Turmaine","year":"2000","unstructured":"Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington\u2019s disease. Proc Natl Acad Sci USA 97:8093\u20138097","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","volume":"404","author":"A Dellen van","year":"2000","unstructured":"van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying he onset of Huntington\u2019s in mice. Nature 404:721\u2013722","journal-title":"Nature"},{"key":"306_CR106","doi-asserted-by":"crossref","unstructured":"von H\u00f6rsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Menezes AM, Vieira-Saecker AMM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li X-J, Riess O (2003) Transgenic rat model of Huntington\u2019s disease. Hum Mol Genet 12. doi: 10.1093\/hmg\/ddg075","DOI":"10.1093\/hmg\/ddg075"},{"key":"306_CR107","first-page":"107","volume":"148","author":"J-P Vonsattel","year":"1992","unstructured":"Vonsattel J-P, Myers RH, Bird ED, Ge P, Richardson EP Jr (1992) Maladie de Huntington: sept cas avec \u00eelots n\u00e9ostriataux relativement pr\u00e9serv\u00e9s. Rev Neurol 148:107\u2013116","journal-title":"Rev Neurol"},{"key":"306_CR108","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR109","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"J-PG Vonsattel","year":"1998","unstructured":"Vonsattel J-PG, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"306_CR110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/326194a0","volume":"326","author":"NS Wexler","year":"1987","unstructured":"Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, Snodgrass SR, Shoulson I, Gomez F, Arroyo MAR, Penchaszadeh GK, Moreno H, Gibbons K, Faryniarz A, Hobbs W, Anderson MA, Bonilla E, Conneally PM, Gusella JF (1987) Homozygotes for Huntington\u2019s disease. Nature 326:194\u2013197","journal-title":"Nature"},{"key":"306_CR111","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst C-A, Vrbanac V, Weaver M, Li X-J, Li S-H, Yi H, Vonsattel J-P, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh Q92 and Hdh Q111 knock-in mice. Hum Mol Genet 9:503\u2013513","journal-title":"Hum Mol Genet"},{"key":"306_CR112","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel J-P, Gusella JF, Joyner AL, MacDonald ME (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat Genet 17:404\u2013410","journal-title":"Nat Genet"},{"key":"306_CR113","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","volume":"23","author":"Z-X Yu","year":"2003","unstructured":"Yu Z-X, Li S-H, Evans J, Pillarisetti A, Li H, Li X-J (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington\u2019s disease. J Neurosci 23:2193\u20132202","journal-title":"J Neurosci"},{"key":"306_CR114","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.31.2.151","volume":"31","author":"EL Zalneraitis","year":"1981","unstructured":"Zalneraitis EL, Landis DMD, Richardson EP Jr, Selkoe DJ (1981) A comparison of astrocytic structure in cerebral cortex and striatum in Huntington\u2019s disease. Neurology 31:151","journal-title":"Neurology"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0306-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-007-0306-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0306-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:23:15Z","timestamp":1559049795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-007-0306-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,3]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,29]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1007\/s00401-007-0306-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,3]]}}}